OBJECTIVES: To determine risk factors of accelerated atherosclerosis and progression of intima-media thickness (IMT) in patients with systemic lupus erythematosus (SLE). METHODS: 74 SLE patients, age ranging from 13 to 69 years, and 74 age- and sex-matched controls were included. IMT of the common carotid artery was determined by B-mode ultrasound imaging. Traditional risk factors for atherosclerosis and disease-related factors were recorded. Cardiovascular risk was estimated using systematic coronary risk evaluation (SCORE). Markers of inflammation (C-reactive protein, CRP) and endothelial activation (thrombomodulin, vascular cell adhesion molecule-1, and von Willebrand factor) were determined. Measurements were repeated in 52 patients after a follow-up of 32+/-7 months. RESULTS: IMT was increased in SLE patients compared to controls. Prevalence of smoking and hypertension, use of lipid-lowering drugs and SCORE were higher in patients, as well as levels of CRP and markers of endothelial activation. The age-related increase in IMT was significantly higher in patients than in controls. In multivariate analysis, age and disease duration was independently related to IMT. Increase in IMT during follow-up was related to age only. CONCLUSION: The age-related increase in IMT is higher in SLE, indicating that atherosclerosis is accelerated in SLE patients. This is mainly due to disease-related risk factors, as disease duration was independently associated with IMT.
OBJECTIVES: To determine risk factors of accelerated atherosclerosis and progression of intima-media thickness (IMT) in patients with systemic lupus erythematosus (SLE). METHODS: 74 SLEpatients, age ranging from 13 to 69 years, and 74 age- and sex-matched controls were included. IMT of the common carotid artery was determined by B-mode ultrasound imaging. Traditional risk factors for atherosclerosis and disease-related factors were recorded. Cardiovascular risk was estimated using systematic coronary risk evaluation (SCORE). Markers of inflammation (C-reactive protein, CRP) and endothelial activation (thrombomodulin, vascular cell adhesion molecule-1, and von Willebrand factor) were determined. Measurements were repeated in 52 patients after a follow-up of 32+/-7 months. RESULTS: IMT was increased in SLEpatients compared to controls. Prevalence of smoking and hypertension, use of lipid-lowering drugs and SCORE were higher in patients, as well as levels of CRP and markers of endothelial activation. The age-related increase in IMT was significantly higher in patients than in controls. In multivariate analysis, age and disease duration was independently related to IMT. Increase in IMT during follow-up was related to age only. CONCLUSION: The age-related increase in IMT is higher in SLE, indicating that atherosclerosis is accelerated in SLEpatients. This is mainly due to disease-related risk factors, as disease duration was independently associated with IMT.
Authors: Hans L A Nienhuis; Karina de Leeuw; Johan Bijzet; Jasper J van Doormaal; Arie M van Roon; Andries J Smit; Reindert Graaff; Cees G M Kallenberg; Marc Bijl Journal: Arthritis Res Ther Date: 2010-09-28 Impact factor: 5.156
Authors: Aleksandra Djokovic; Lj Stojanovich; N Stanisavljevic; V Bisenic; S Radovanovic; I Soldatovic; D V Simic Journal: Rheumatol Int Date: 2013-11-15 Impact factor: 2.631
Authors: Maureen McMahon; Brian J Skaggs; Lori Sahakian; Jennifer Grossman; John FitzGerald; Nagesh Ragavendra; Christina Charles-Schoeman; Marissa Chernishof; Alan Gorn; Joseph L Witztum; Weng Kee Wong; Michael Weisman; Daniel J Wallace; Antonio La Cava; Bevra H Hahn Journal: Ann Rheum Dis Date: 2011-06-13 Impact factor: 19.103
Authors: Rosa W Telles; Cristina C D Lanna; Adriano J Sousa; Tulio P Navarro; Fabiana L Souza; Luciana A Rodrigues; Rodrigo C P Reis; Antonio L Ribeiro Journal: Clin Rheumatol Date: 2013-04-26 Impact factor: 3.650
Authors: Sahar Nassef; Hala El Guindey; Mary Fawzy; Amal Nasser; Rasha Reffai; Doa Shemiy Journal: Arch Rheumatol Date: 2015-10-06 Impact factor: 1.472